http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2004074240-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14 |
| filingDate | 2004-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2004074240-A1 |
| titleOfInvention | Prostaglandin derivatives |
| abstract | formula (In the formula, X represents a halogen atom, Y represents an ethylene group, vinylene group or ethynylene group, and Z represents — (CH 2 ) m —, —O (CH 2 ) n — or —S (O) p —). (CH 2 ) n — (m represents an integer of 0 to 3, n represents an integer of 0 to 2, and p represents an integer of 0 to 2), R 1 represents a hydrogen atom, an alkyl or substituted C 1-5 alkyl group C 1-5, R 2 is or a cycloalkyl group C 3-10 substituted with C 3 -10 cycloalkyl group, a C 1-4 alkyl group A C 4-15 cycloalkylalkyl group, and R 3 represents a hydrogen atom, a halogen atom, a C 1-5 alkyl group or a substituted C 1-5 alkyl group.), A prostaglandin derivative represented by A pharmaceutically acceptable salt or hydrate thereof is prostag It has an excellent antagonistic effect on ninjin DP receptor, so it is useful for diseases such as allergic rhinitis, nasal congestion, asthma, allergic conjunctivitis, systemic mastocytosis, systemic mast cell activation disorder . |
| priorityDate | 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 185.